Mesenchymal–epithelial transition (MET) as a mechanism for metastatic colonisation in breast cancer
The DOI matches its Crossref record; 95 of the 95 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219 · cited 1×
“Although uncontrolled epithelial proliferation and angiogenesis (7) are major facilitating mechanisms in metastasis, additional processes are needed for the successful establishment of a”
Prospective identification of tumorigenic breast cancer cells
Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,370
Epithelial-Mesenchymal Transitions in Development and Disease
Thiery, J. P., Acloque, H., Huang, R. Y. J., & Nieto, M. A. (2009) · Cell · doi:10.1016/j.cell.2009.11.007 · Cited by 9,931
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
Mani, S. A., Guo, W., Liao, M.-J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., Brooks, M., Reinhard, F., Zhang, C. C., Shipitsin, M., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.027 · Cited by 8,672
Epithelial–mesenchymal transitions in tumour progression
Thiery, J. P. (2002) · Nature Reviews Cancer · doi:10.1038/nrc822 · Cited by 6,628
Tumor Metastasis: Molecular Insights and Evolving Paradigms
Valastyan, S., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.09.024 · Cited by 4,011
Dissemination and growth of cancer cells in metastatic sites
Chambers, A. F., Groom, A. C., & MacDonald, I. C. (2002) · Nature Reviews Cancer · doi:10.1038/nrc865 · Cited by 3,911
Epithelial-Mesenchymal Transition: At the Crossroads of Development and Tumor Metastasis
Yang, J., & Weinberg, R. A. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.05.009 · Cited by 3,012
Folkman, J., & Shing, Y. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49853-0 · Cited by 2,654
Polychemotherapy for early breast cancer: an overview of the randomised trials
(1998) · The Lancet · doi:10.1016/s0140-6736(98)03301-7 · Cited by 2,042
The epithelial–mesenchymal transition: new insights in signaling, development, and disease
Lee, J. M., Dedhar, S., Kalluri, R., & Thompson, E. W. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200601018 · Cited by 2,019
Self-citationEMT, the cytoskeleton, and cancer cell invasion
Yilmaz, M., & Christofori, G. (2009) · Cancer and Metastasis Reviews · doi:10.1007/s10555-008-9169-0 · Cited by 1,788
Weidner, N., Folkman, J., Pozza, F., Bevilacqua, P., Allred, E. N., Moore, D. H., Meli, S., & Gasparini, G. (1992) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/84.24.1875 · Cited by 1,775
Burk, U., Schubert, J., Wellner, U., Schmalhofer, O., Vincan, E., Spaderna, S., & Brabletz, T. (2008) · EMBO reports · doi:10.1038/embor.2008.74 · Cited by 1,722
A causal role for E-cadherin in the transition from adenoma to carcinoma
Perl, A.-K., Wilgenbus, P., Dahl, U., Semb, H., & Christofori, G. (1998) · Nature · doi:10.1038/32433 · Cited by 1,424
Breast cancer statistics, 2011
DeSantis, C., Siegel, R., Bandi, P., & Jemal, A. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20134 · Cited by 1,326
Multistep Nature of Metastatic Inefficiency
Luzzi, K. J., MacDonald, I. C., Schmidt, E. E., Kerkvliet, N., Morris, V. L., Chambers, A. F., & Groom, A. C. (1998) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65628-3 · Cited by 1,243
Real-time imaging reveals the single steps of brain metastasis formation.
Kienast, Y., von Baumgarten, L., Fuhrmann, M., Klinkert, W. E. F., Goldbrunner, R., Herms, J., & Winkler, F. (2010) · Nature Medicine · doi:10.1038/nm.2072 · Cited by 1,138 · cited 1×
“The fate of DTCs at the ectopic site varies, although the vast majority of these cells do not survive even a week under experimental conditions [16, 17].”
Epithelial—mesenchymal and mesenchymal—epithelial transitions in carcinoma progression
Hugo, H., Ackland, M. L., Blick, T., Lawrence, M. G., Clements, J. A., Williams, E. D., & Thompson, E. W. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21223 · Cited by 1,091
Self-citationBIRCHMEIER, W., & BEHRENS, J. (1994) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(94)90003-5 · Cited by 1,002
Snail blocks the cell cycle and confers resistance to cell death
Vega, S., Morales, A. V., Ocaña, O. H., Valdés, F., Fabregat, I., & Nieto, M. A. (2004) · Genes & Development · doi:10.1101/gad.294104 · Cited by 867
Metastasis genes: A progression puzzle
Bernards, R., & Weinberg, R. A. (2002) · Nature · doi:10.1038/418823a · Cited by 798
The ZEB/miR‐200 feedback loop—a motor of cellular plasticity in development and cancer?
Brabletz, S., & Brabletz, T. (2010) · EMBO reports · doi:10.1038/embor.2010.117 · Cited by 793
Ansieau, S., Bastid, J., Doreau, A., Morel, A.-P., Bouchet, B. P., Thomas, C., Fauvet, F., Puisieux, I., Doglioni, C., Piccinin, S., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.06.005 · Cited by 715
Sporn, M. B. (1996) · The Lancet · doi:10.1016/s0140-6736(96)91015-6 · Cited by 692
Long-term human breast carcinoma cell lines of metastatic origin: Preliminary characterization
Cailleau, R., Olivé, M., & Cruciger, Q. V. J. (1978) · In Vitro · doi:10.1007/bf02616120 · Cited by 679
Thomson, S., Buck, E., Petti, F., Griffin, G., Brown, E., Ramnarine, N., Iwata, K. K., Gibson, N., & Haley, J. D. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1058 · Cited by 663
Korpal, M., Ell, B. J., Buffa, F. M., Ibrahim, T., Blanco, M. A., Celià-Terrassa, T., Mercatali, L., Khan, Z., Goodarzi, H., Hua, Y., et al. (2011) · Nature Medicine · doi:10.1038/nm.2401 · Cited by 636
Lo, H.-W., Hsu, S.-C., Xia, W., Cao, X., Shih, J.-Y., Wei, Y., Abbruzzese, J. L., Hortobagyi, G. N., & Hung, M.-C. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0575 · Cited by 625
General mechanisms of metastasis
Woodhouse, E. C., Chuaqui, R. F., & Liotta, L. A. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19971015)80:8+<1529::aid-cncr2>3.0.co;2-f · Cited by 581
Epithelial-Mesenchymal Transition
Klymkowsky, M. W., & Savagner, P. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.080545 · Cited by 557
Gregory, P. A., Bracken, C. P., Smith, E., Bert, A. G., Wright, J. A., Roslan, S., Morris, M., Wyatt, L., Farshid, G., Lim, Y.-Y., et al. (2011) · Molecular Biology of the Cell · doi:10.1091/mbc.e11-02-0103 · Cited by 552
Cooke, V. G., LeBleu, V. S., Keskin, D., Khan, Z., O'Connell, J. T., Teng, Y., Duncan, M. B., Xie, L., Maeda, G., Vong, S., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2011.11.024 · Cited by 530
Thompson, E. W., Paik, S., Brünner, N., Sommers, C. L., Zugmaier, G., Clarke, R., Shima, T. B., Torri, J., Donahue, S., Lippman, M. E., et al. (1992) · Journal of Cellular Physiology · doi:10.1002/jcp.1041500314 · Cited by 523
Self-citationYauch, R. L., Januario, T., Eberhard, D. A., Cavet, G., Zhu, W., Fu, L., Pham, T. Q., Soriano, R., Stinson, J., Seshagiri, S., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1492 · Cited by 495 · cited 1×
“particularly evident in non small cell lung cancer responses to EGFR-targeted therapies, seen both experimentally and in patients (92-94).”
Spaderna, S., Schmalhofer, O., Hlubek, F., Berx, G., Eger, A., Merkel, S., Jung, A., Kirchner, T., & Brabletz, T. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.06.016 · Cited by 476
Chaffer, C. L., Brennan, J. P., Slavin, J. L., Blick, T., Thompson, E. W., & Williams, E. D. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2044 · Cited by 455
Self-citationCelià-Terrassa, T., Meca-Cortés, Ó., Mateo, F., Martínez de Paz, A., Rubio, N., Arnal-Estapé, A., Ell, B. J., Bermudo, R., Díaz, A., Guerra-Rebollo, M., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59218 · Cited by 450
New insights into the role of extracellular matrix during tumor onset and progression
Pupa, S. M., Ménard, S., Forti, S., & Tagliabue, E. (2002) · Journal of Cellular Physiology · doi:10.1002/jcp.10142 · Cited by 419
E-cadherin expression in primary carcinomas of the breast and its distant metastases
Kowalski, P. J., Rubin, M. A., & Kleer, C. G. (2003) · Breast Cancer Research · doi:10.1186/bcr651 · Cited by 414
Breast carcinoma cells re-express E-cadherin during mesenchymal to epithelial reverting transition
Chao, Y. L., Shepard, C. R., & Wells, A. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-179 · Cited by 411
Self-citationTumor suppressor gene E-cadherin and its role in normal and malignant cells
Pećina-Šlaus, N. (2003) · Cancer Cell International · doi:10.1186/1475-2867-3-17 · Cited by 394
Hurteau, G. J., Carlson, J. A., Spivack, S. D., & Brock, G. J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1058 · Cited by 390
Fisher, B., Jeong, J.-H., Bryant, J., Anderson, S., Dignam, J., Fisher, E. R., & Wolmark, N. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16981-x · Cited by 359
Wells, A., Yates, C., & Shepard, C. R. (2008) · Clinical & Experimental Metastasis · doi:10.1007/s10585-008-9167-1 · Cited by 353
Self-citationMesenchymal to Epithelial Transition in Development and Disease
Chaffer, C. L., Thompson, E. W., & Williams, E. D. (2007) · Cells Tissues Organs · doi:10.1159/000101298 · Cited by 324
Self-citationGao, D., Joshi, N., Choi, H., Ryu, S., Hahn, M., Catena, R., Sadik, H., Argani, P., Wagner, P., Vahdat, L. T., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2905 · Cited by 307
Invasive lobular carcinoma of the breast: incidence and variants
MARTINEZ, V., & AZZOPARDI, J. G. (1979) · Histopathology · doi:10.1111/j.1365-2559.1979.tb03029.x · Cited by 303
Blick, T., Hugo, H., Widodo, E., Waltham, M., Pinto, C., Mani, S. A., Weinberg, R. A., Neve, R. M., Lenburg, M. E., & Thompson, E. W. (2010) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-010-9175-z · Cited by 292
Self-citationExpression profiling of microRNAs by deep sequencing
Creighton, C. J., Reid, J. G., & Gunaratne, P. H. (2009) · Briefings in Bioinformatics · doi:10.1093/bib/bbp019 · Cited by 288
uPAR induces epithelial–mesenchymal transition in hypoxic breast cancer cells
Lester, R. D., Jo, M., Montel, V., Takimoto, S., & Gonias, S. L. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200701092 · Cited by 253
Valdés, F., Alvarez, A. M., Locascio, A., Vega, S., Herrera, B. M., Fernández, M., Benito, M., Nieto, M. A., & Fabregat, I. (2002) · PubMed · Cited by 249
Creighton, C. J., Chang, J. C., & Rosen, J. M. (2010) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-010-9173-1 · Cited by 242
Cadherin-11 is expressed in invasive breast cancer cell lines.
Pishvaian, M. J., Feltes, C. M., Thompson, P., Bussemakers, M. J. G., Schalken, J. A., & Byers, S. W. (1999) · PubMed · Cited by 238
Snail Family Regulation and Epithelial Mesenchymal Transitions in Breast Cancer Progression
de Herreros, A. G., Peiró, S., Nassour, M., & Savagner, P. (2010) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-010-9179-8 · Cited by 237
Tsuji, T., Ibaragi, S., Shima, K., Hu, M. G., Katsurano, M., Sasaki, A., & Hu, G.-F. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1444 · Cited by 236
Epithelial-mesenchymal transition in breast cancer progression and metastasis
Wang, Y., & Zhou, B. P. (2011) · Chinese Journal of Cancer · doi:10.5732/cjc.011.10226 · Cited by 235
Cloning and characterization of the human invasion suppressor gene E-cadherin (CDH1)
Berx, G., Staes, K., van Hengel, J., Molemans, F., Bussemakers, M. J. G., van Bokhoven, A., & van Roy, F. (1995) · Genomics · doi:10.1016/0888-7543(95)80212-5 · Cited by 221
Jung, A., Schrauder, M., Oswald, U., Knoll, C., Sellberg, P., Palmqvist, R., Niedobitek, G., Brabletz, T., & Kirchner, T. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63007-6 · Cited by 217 · cited 1×
“Another study by the same group has demonstrated a higher expression of cell cycle inhibitor, p16 (inhibitor of kinase 4), in the invasive front of well-differentiated colorectal carcinomas where β-catenin is localized in the nucleus, when compared to the p16-negative cells with cytoplasmic β-catenin comprising the ce…”
Persistent E-Cadherin Expression in Inflammatory Breast Cancer
Kleer, C. G., van Golen, K. L., Braun, T., & Merajver, S. D. (2001) · Modern Pathology · doi:10.1038/modpathol.3880334 · Cited by 214
Stessels, F., Van den Eynden, G., Van der Auwera, I., Salgado, R., Van den Heuvel, E., Harris, A. L., Jackson, D. G., Colpaert, C. G., Van Marck, E. A., Dirix, L. Y., et al. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601727 · Cited by 214
Gal, A., Sjöblom, T., Fedorova, L., Imreh, S., Beug, H., & Moustakas, A. (2008) · Oncogene · doi:10.1038/sj.onc.1210741 · Cited by 212
Mejlvang, J., Kriajevska, M., Vandewalle, C., Chernova, T., Sayan, A. E., Berx, G., Mellon, J. K., & Tulchinsky, E. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-05-0406 · Cited by 207
Bonnomet, A., Syne, L., Brysse, A., Feyereisen, E., Thompson, E. W., Noël, A., Foidart, J.-M., Birembaut, P., Polette, M., & Gilles, C. (2012) · Oncogene · doi:10.1038/onc.2011.540 · Cited by 201
Self-citationBendoraite, A., Knouf, E. C., Garg, K. S., Parkin, R. K., Kroh, E. M., O'Briant, K. C., Ventura, A. P., Godwin, A. K., Karlan, B. Y., Drescher, C. W., et al. (2010) · Gynecologic Oncology · doi:10.1016/j.ygyno.2009.08.009 · Cited by 199
Sayan, A. E., Griffiths, T. R., Pal, R., Browne, G. J., Ruddick, A., Yagci, T., Edwards, R., Mayer, N. J., Qazi, H., Goyal, S., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0902042106 · Cited by 192
Thomson, S., Petti, F., Sujka-Kwok, I., Epstein, D., & Haley, J. D. (2008) · Clinical & Experimental Metastasis · doi:10.1007/s10585-008-9200-4 · Cited by 190
Global breast cancer mortality statistics
Mettlin, C. (1999) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.49.3.138 · Cited by 187
Howlett, A. R., & Bissell, M. J. (1993) · PubMed · Cited by 185
Down-regulation of epithelial cadherin is required to initiate metastatic outgrowth of breast cancer
Wendt, M. K., Taylor, M. A., Schiemann, B. J., & Schiemann, W. P. (2011) · Molecular Biology of the Cell · doi:10.1091/mbc.e11-04-0306 · Cited by 178
Jo, M., Lester, R. D., Montel, V., Eastman, B., Takimoto, S., & Gonias, S. L. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.023960 · Cited by 175
Aberrant Expression of E-cadherin in Lobular Carcinomas of the Breast
Silva, L. D., Parry, S., Reid, L., Keith, P., Waddell, N., Kossai, M., Clarke, C., Lakhani, S. R., & Simpson, P. T. (2008) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e318158d6c5 · Cited by 173
Partial Mesenchymal to Epithelial Reverting Transition in Breast and Prostate Cancer Metastases
Chao, Y., Wu, Q., Acquafondata, M., Dhir, R., & Wells, A. (2012) · Cancer Microenvironment · doi:10.1007/s12307-011-0085-4 · Cited by 169
Self-citationMetastatic Breast Cancer: The Treatment Challenge
Jones, S. E. (2008) · Clinical Breast Cancer · doi:10.3816/cbc.2008.n.025 · Cited by 166
(1980) · PubMed · Cited by 154
Mechanisms of inactivation of E-cadherin in breast cancer cell lines.
Hiraguri, S., Godfrey, T. E., Nakamura, H., Graff, J. R., Collins, C. C., Shayesteh, L., Doggett, N. A., Johnson, K. J., Wheelock, M. J., Herman, J. G., et al. (1998) · PubMed · Cited by 149
Bullock, M. D., Sayan, E., Packham, G. K., & Mirnezami, A. H. (2011) · Biology of the Cell · doi:10.1111/boc.201100115 · Cited by 148
Yates, C. C., Shepard, C. R., Stolz, D. B., & Wells, A. H. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603700 · Cited by 148
Self-citationThe p53-binding protein MDM2 gene is differentially expressed in human breast carcinoma.
Sheikh, M. S., Shao, Z. M., Hussain, A., & Fontana, J. A. (1993) · PubMed · Cited by 143
Prognosis in Infiltrating Lobular Carcinoma: An Analysis of “Classical” and Variant Tumors
DiCostanzo, D., Rosen, P. P., Gareen, I., Franklin, S., & Lesser, M. (1990) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199001000-00002 · Cited by 138
Oltean, S., Sorg, B. S., Albrecht, T. R., Bonano, V. I., Brazas, R. M., Dewhirst, M. W., & García-Blanco, M. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603090103 · Cited by 127
Lang, S. H., Sharrard, R. M., Stark, M., Villette, J. M., & Maitland, N. J. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1967 · Cited by 106
Kurahara, H., Takao, S., Maemura, K., Mataki, Y., Kuwahata, T., Maeda, K., Ding, Q., Sakoda, M., Iino, S., Ishigami, S., et al. (2011) · Journal of Surgical Oncology · doi:10.1002/jso.23020 · Cited by 101
Bastid, J. (2012) · Cancer and Metastasis Reviews · doi:10.1007/s10555-011-9344-6 · Cited by 99
Jechlinger, M., Grünert, S., & Beug, H. (2002) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1024090116451 · Cited by 96
Epithelial and mesenchymal phenotypic switchings modulate cell motility in metastasis
Wells, A. H., Chao, Y. L., Grahovac, J., Wu, Q., & Lauffenburger, D. A. (2010) · Frontiers in bioscience · doi:10.2741/3722 · Cited by 94
Self-citationChao, Y. L., Wu, Q., Shepard, C. R., & Wells, A. H. (2011) · Clinical & Experimental Metastasis · doi:10.1007/s10585-011-9427-3 · Cited by 92
Self-citationLopes, N., Carvalho, J., Durães, C., Sousa, B., Gomes, M., Costa, J. L., Oliveíra, C., Paredes, J., & Schmitt, F. C. (2012) · PubMed · Cited by 82
E–N-cadherin heterodimers define novel adherens junctions connecting endoderm-derived cells
Straub, B. K., Rickelt, S., Zimbelmann, R., Gründ, C., Kuhn, C., Iken, M., Ott, M., Schirmacher, P., & Franke, W. W. (2011) · The Journal of Cell Biology · doi:10.1083/jcb.201106023 · Cited by 65
Expression and ligand binding of α2β1 integrin on breast carcinoma cells
Maemura, M., Akiyama, S. K., Woods, V. L., & Dickson, R. B. (1995) · Clinical & Experimental Metastasis · doi:10.1007/bf00133478 · Cited by 46
Tumour–stroma interactions in carcinogenesis: Basic aspects and perspectives
Kiaris, H., Chatzistamou, I., Kalofoutis, C., Koutselini, H., Piperi, C., & Kalofoutis, A. (2004) · Molecular and Cellular Biochemistry · doi:10.1023/b:mcbi.0000028746.54447.6c · Cited by 41
Oltean, S., Febbo, P. G., & García-Blanco, M. A. (2008) · Clinical & Experimental Metastasis · doi:10.1007/s10585-008-9186-y · Cited by 39
López‐Tarruella, S., & Martín, M. (2009) · Breast Cancer Research · doi:10.1186/bcr2226 · Cited by 33
Rubio‐Terres, C. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.04839.x · Cited by 20
Cited by
EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
Shibue, T., & Weinberg, R. A. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.44 · Cited by 2,539
Fischer, K. R., Durrans, A., Lee, S., Sheng, J., Li, F., Wong, S. T. C., Choi, H., El Rayes, T., Ryu, S., Troeger, J., et al. (2015) · Nature · doi:10.1038/nature15748 · Cited by 1,791
EMT, cell plasticity and metastasis
Chaffer, C. L., San Juan, B. P., Lim, E., & Weinberg, R. A. (2016) · Cancer and Metastasis Reviews · doi:10.1007/s10555-016-9648-7 · Cited by 861
Motility-Driven Glass and Jamming Transitions in Biological Tissues
Bi, D., Yang, X., Marchetti, M. C., & Manning, M. L. (2016) · Physical Review X · doi:10.1103/physrevx.6.021011 · Cited by 677
Controversies around epithelial–mesenchymal plasticity in cancer metastasis
Williams, E. D., Gao, D., Redfern, A., & Thompson, E. W. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0213-x · Cited by 451
Self-citation
Metadata
- Authors
- Gunasinghe, N. P. A. D., Wells, A., Thompson, E. W., & Hugo, H. J.
- Venue
- Cancer and Metastasis Reviews
- Published
- 2012-06-23
- Volume
- 31
- Issue
- 3-4
- Pages
- 469-478
- ISSN
- 0167-7659 (ISSN-L)
- 1573-7233
- OpenAlex
- W1536326448
- Cited by
- 339
- References
- 95
- FWCI
- 3.05
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.